{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:16:02Z","timestamp":1779387362632,"version":"3.53.1"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:p>Radiation therapy (RT) has long been an important part of the history of curative treatment for Hodgkin Lymphoma since the pioneering work of Vera Peters, MD and Henry Kaplan, MD. The contemporary role of radiation therapy in the management of patients with early-stage favorable and unfavorable disease, advanced disease, and relapsed\/refractory disease will be explored. Seminal clinical trials that highlight the critical role of RT in local control and progression-free survival will be reviewed. The interest in combined modality therapy (CMT) (combination of chemotherapy and RT) will be explored as well as the use of CMT with emphasis on cost effectiveness, age and sex, and risk profile including secondary malignancy and cardiac toxicity compared with chemotherapy alone. Contemporary radiation treatment volumes, techniques, and doses will be discussed as modern strategies to mitigate late toxicities while maintaining efficacy.<\/jats:p>","DOI":"10.1097\/ppo.0000000000000826","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:00:25Z","timestamp":1779386425000},"update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy in the Modern Treatment of Hodgkin Lymphoma"],"prefix":"10.1097","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9669-8241","authenticated-orcid":false,"given":"Joseph","family":"Carmicheal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Enke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,5]]},"reference":[{"key":"R1-20260521","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1200\/JCO.23.01745","article-title":"Long-term follow-up of the response-adapted intergroup EORTC\/LYSA\/FIL H10 trial for localized Hodgkin lymphoma","volume":"42","author":"Federico","year":"2024","journal-title":"J Clin Oncol"},{"key":"R2-20260521","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/s41375-023-02064-y","article-title":"Follow-up of the GHSG HD16 trial of PET-guided treatment in early-stage favorable Hodgkin lymphoma","volume":"38","author":"Fuchs","year":"2024","journal-title":"Leukemia"},{"key":"R3-20260521","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1200\/JCO.2009.26.0323","article-title":"Consolidation radiotherapy in patients with advanced Hodgkin\u2019s lymphoma: survival data from the UKLG LY09 randomized controlled trial (ISRCTN97144519)","volume":"28","author":"Johnson","year":"2010","journal-title":"J Clin Oncol"},{"key":"R4-20260521","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1200\/JCO.2009.25.3260","article-title":"Treatment of favorable, limited-stage Hodgkin\u2019s lymphoma with chemotherapy without consolidation by radiation therapy","volume":"28","author":"Canellos","year":"2010","journal-title":"J Clin Oncol"},{"key":"R5-20260521","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1056\/NEJMoa1111961","article-title":"ABVD alone versus radiation-based therapy in limited-stage Hodgkin\u2019s lymphoma","volume":"366","author":"Meyer","year":"2012","journal-title":"N Engl J Med"},{"key":"R6-20260521","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1470-2045(20)30601-X","article-title":"PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial","volume":"22","author":"Borchmann","year":"2021","journal-title":"Lancet Oncol"},{"key":"R7-20260521","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clml.2015.11.006","article-title":"Trends in use of radiation therapy for Hodgkin lymphoma from 2000 to 2012 on the basis of the National Cancer Database","volume":"16","author":"Goyal","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R8-20260521","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S1470-2045(25)00262-1","article-title":"Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial","volume":"26","author":"Ferdinandus","year":"2025","journal-title":"Lancet Oncol"},{"key":"R9-20260521","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1200\/JCO.21.00408","article-title":"Predicted risks of cardiovascular disease following chemotherapy and radiotherapy in the UK NCRI RAPID trial of positron emission tomography-directed therapy for early-stage Hodgkin lymphoma","volume":"39","author":"Cutter","year":"2021","journal-title":"J Clin Oncol"},{"key":"R10-20260521","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1056\/NEJMoa1408648","article-title":"Results of a trial of PET-directed therapy for early-stage Hodgkin\u2019s lymphoma","volume":"372","author":"Radford","year":"2015","journal-title":"N Engl J Med"},{"key":"R11-20260521","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 Trial","volume":"35","author":"Andre","year":"2017","journal-title":"J Clin Oncol"},{"key":"R12-20260521","doi-asserted-by":"crossref","first-page":"e992","DOI":"10.1016\/j.clml.2022.07.005","article-title":"Cost-effectiveness of PET directed versus combined modality therapy for early-stage favorable Hodgkin\u2019s lymphoma","volume":"22","author":"Smith","year":"2022","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"R13-20260521","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/cncr.29841","article-title":"Therapeutic radiation and the potential risk of second malignancies","volume":"122","author":"Kamran","year":"2016","journal-title":"Cancer"},{"key":"R14-20260521","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1182\/bloodadvances.2021006254","article-title":"Informing radiotherapy decisions in stage I\/IIa Hodgkin lymphoma: modeling life expectancy using radiation dosimetry","volume":"6","author":"Jones","year":"2022","journal-title":"Blood Adv"},{"key":"R15-20260521","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S1470-2045(05)70387-9","article-title":"Lung cancer after treatment for Hodgkin\u2019s lymphoma: a systematic review","volume":"6","author":"Lorigan","year":"2005","journal-title":"Lancet Oncol"},{"key":"R16-20260521","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1001\/jamainternmed.2015.1180","article-title":"Cardiovascular disease after Hodgkin lymphoma treatment: 40-year disease risk","volume":"175","author":"van Nimwegen","year":"2015","journal-title":"JAMA Intern Med"},{"key":"R17-20260521","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMra1003733","article-title":"Early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Armitage","year":"2010","journal-title":"N Engl J Med"},{"key":"R18-20260521","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin\u2019s disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"R19-20260521","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1505949","article-title":"Second cancer risk up to 40 years after treatment for Hodgkin\u2019s lymphoma","volume":"373","author":"Schaapveld","year":"2015","journal-title":"N Engl J Med"},{"key":"R20-20260521","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1200\/JCO.23.01386","article-title":"Doxorubicin exposure and breast cancer risk in survivors of adolescent and adult Hodgkin lymphoma","volume":"42","author":"Neppelenbroek","year":"2024","journal-title":"J Clin Oncol"},{"key":"R21-20260521","doi-asserted-by":"crossref","first-page":"104499","DOI":"10.1016\/j.critrevonc.2024.104499","article-title":"Management of peripheral neuropathy associated with brentuximab vedotin in the frontline treatment of classical Hodgkin lymphoma","volume":"204","author":"Abramson","year":"2024","journal-title":"Crit Rev Oncol Hematol"},{"key":"R22-20260521","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1080\/0284186X.2021.1917776","article-title":"Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin\u2019s lymphoma: symptom burden and quality of life","volume":"60","author":"Eikeland","year":"2021","journal-title":"Acta Oncol"},{"key":"R23-20260521","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hon.939","article-title":"Fertility preservation after chemotherapy for Hodgkin lymphoma","volume":"28","author":"van der Kaaij","year":"2010","journal-title":"Hematol Oncol"},{"key":"R24-20260521","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/ejh.12737","article-title":"Fertility in premenopausal women post autologous stem cell transplant with BEAM conditioning","volume":"97","author":"Lasica","year":"2016","journal-title":"Eur J Haematol"},{"key":"R25-20260521","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijrobp.2016.10.004","article-title":"Secondary breast cancer risk by radiation volume in women with Hodgkin lymphoma","volume":"97","author":"Conway","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R26-20260521","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1016\/j.ijrobp.2011.09.020","article-title":"Risk of developing cardiovascular disease after involved node radiotherapy versus mantle field for Hodgkin lymphoma","volume":"83","author":"Maraldo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R27-20260521","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1111\/bjh.16232","article-title":"No excess long-term mortality in stage I-IIA Hodgkin lymphoma patients treated with ABVD and limited field radiotherapy","volume":"188","author":"Lagerlof","year":"2020","journal-title":"Br J Haematol"},{"key":"R28-20260521","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.ijrobp.2020.03.019","article-title":"Involved site radiation therapy in adult lymphomas: an overview of International Lymphoma Radiation Oncology Group Guidelines","volume":"107","author":"Wirth","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R29-20260521","doi-asserted-by":"crossref","first-page":"103437","DOI":"10.1016\/j.critrevonc.2021.103437","article-title":"A systematic review on intensity modulated radiation therapy for Mediastinal Hodgkin\u2019s lymphoma","volume":"167","author":"Buglione","year":"2021","journal-title":"Crit Rev Oncol Hematol"},{"key":"R30-20260521","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1186\/1748-717X-7-186","article-title":"Different IMRT solutions vs. 3D-conformal radiotherapy in early stage Hodgkin\u2019s Lymphoma: dosimetric comparison and clinical considerations","volume":"7","author":"Fiandra","year":"2012","journal-title":"Radiat Oncol"},{"key":"R31-20260521","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijrobp.2005.06.004","article-title":"Is intensity-modulated radiotherapy better than conventional radiation treatment and three-dimensional conformal radiotherapy for mediastinal masses in patients with Hodgkin\u2019s disease, and is there a role for beam orientation optimization and dose constraints assigned to virtual volumes?","volume":"64","author":"Girinsky","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R32-20260521","doi-asserted-by":"crossref","first-page":"690","DOI":"10.3390\/cancers16040690","article-title":"Dosimetric impact of voluntary deep inspiration breath hold (DIBH) in mediastinal Hodgkin lymphomas: a comparative evaluation of three different intensity modulated radiation therapy (IMRT) delivery methods using voluntary DIBH and free breathing techniques","volume":"16","author":"Mohanty","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R33-20260521","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1056\/NEJMoa1000067","article-title":"Reduced treatment intensity in patients with early-stage Hodgkin\u2019s lymphoma","volume":"363","author":"Engert","year":"2010","journal-title":"N Engl J Med"},{"key":"R34-20260521","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1200\/JCO.2016.70.9410","article-title":"Long-term follow-up of contemporary treatment in early-stage Hodgkin lymphoma: updated analyses of the German Hodgkin study group HD7, HD8, HD10, and HD11 trials","volume":"35","author":"Sasse","year":"2017","journal-title":"J Clin Oncol"},{"key":"R35-20260521","doi-asserted-by":"crossref","first-page":"3746","DOI":"10.3390\/cancers13153746","article-title":"Current situation of proton therapy for Hodgkin lymphoma: from expectations to evidence","volume":"13","author":"Loap","year":"2021","journal-title":"Cancers (Basel)"},{"key":"R36-20260521","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13014-020-1462-2","article-title":"Intensity modulated proton therapy compared to volumetric modulated arc therapy in the irradiation of young female patients with Hodgkin\u2019s lymphoma. Assessment of risk of toxicity and secondary cancer induction","volume":"15","author":"Scorsetti","year":"2020","journal-title":"Radiat Oncol"},{"key":"R37-20260521","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.3390\/cancers16152736","article-title":"Proton pencil beam scanning facilitates the safe treatment of extended radiation targets for Hodgkin lymphoma: a report from the Proton Collaborative Group Registry","volume":"16","author":"Ebadi","year":"2024","journal-title":"Cancers (Basel)"},{"key":"R38-20260521","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13014-018-1066-2","article-title":"Proton versus photon deep inspiration breath hold technique in patients with Hodgkin lymphoma and mediastinal radiation: a planning comparison of deep inspiration breath hold intensity modulation radiotherapy and intensity modulated proton therapy","volume":"13","author":"Baues","year":"2018","journal-title":"Radiat Oncol"},{"key":"R39-20260521","doi-asserted-by":"crossref","first-page":"e2013935","DOI":"10.1001\/jamanetworkopen.2020.13935","article-title":"Assessment of radiation doses delivered to organs at risk among patients with early-stage favorable Hodgkin lymphoma treated with contemporary radiation therapy","volume":"3","author":"Pinnix","year":"2020","journal-title":"JAMA Netw Open"},{"key":"R40-20260521","doi-asserted-by":"crossref","first-page":"b4606","DOI":"10.1136\/bmj.b4606","article-title":"Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort","volume":"339","author":"Mulrooney","year":"2009","journal-title":"BMJ"},{"key":"R41-20260521","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1748-717X-2-13","article-title":"A comparison of mantle versus involved-field radiotherapy for Hodgkin\u2019s lymphoma: reduction in normal tissue dose and second cancer risk","volume":"2","author":"Koh","year":"2007","journal-title":"Radiat Oncol"},{"key":"R42-20260521","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.clon.2015.03.005","article-title":"Involved node, site, field and residual volume radiotherapy for lymphoma: a comparison of organ at risk dosimetry and second malignancy risks","volume":"27","author":"Murray","year":"2015","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000826","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T18:00:30Z","timestamp":1779386430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PPO.0000000000000826"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0000000000000826","relation":{},"ISSN":["1540-336X"],"issn-type":[{"value":"1540-336X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-11-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-13","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}